FONAR Corporation (FONR) is a Medical - Devices company in the Healthcare sector, currently trading at $18.76. It has a SharesGrow Score of 59/100, indicating a above average investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of FONR = $20.34 (+8.4% from the current price, the stock appears fairly valued).
Valuation: FONR trades at a trailing Price-to-Earnings (P/E) of 15.5 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 17.46.
Financials: revenue is $104M, +2.3%/yr average growth. Net income is $8M, growing at -18%/yr. Net profit margin is 8% (thin). Gross margin is 81.7% (+33.5 pp trend).
Balance sheet: total debt is $39M against $173M equity (Debt-to-Equity (D/E) ratio 0.23, conservative). Current ratio is 8.45 (strong liquidity). Debt-to-assets is 17.9%. Total assets: $217M.
SharesGrow 7-Criteria breakdown: Value 30/100 (Fail), Growth 30/100 (Fail), Past 100/100 (Pass), Health 100/100 (Pass), Moat 58/100 (Partial), Future ?/100 (Fail), Income 45/100 (Partial).
